Paweł Jurczak
Paweł Jurczak has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Anna Doboszyńska
Department of Pulmonology, School of Public Health, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland
2 shared publications - Anna Romaszko-Wojtowicz
Department of Pulmonology, School of Public Health, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland
2 shared publications - Dominik Małek
The Regional Specialist Hospital in Olsztyn, Żołnierska 18, 10-561 Olsztyn, Poland
2 shared publications - Klaudia Sztaba
Hospital of the Order of Brothers Hospitallers of St. John Grande, Trynitarska 11, 31-061 Krakow, Poland
2 shared publications - Marta Siwek
St. Adalbert's Hospital, Copernicus PL, al. Jana Pawła II 50, 80-462 Gdańsk, Poland
2 shared publications - Paweł Karol Puczel
St. Adalbert's Hospital, Copernicus PL, al. Jana Pawła II 50, 80-462 Gdańsk, Poland
2 shared publications
Latest Publications
- Open Access
- 30 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
CLINICAL UTILITY OF CYFRA 21-1 IN ONCOLOGY: A COMPREHENSIVE REVIEW OF CURRENT EVIDENCE AND FUTURE DIRECTIONS
CYFRA 21-1, a soluble fragment of cytokeratin-19 released during epithelial cell apoptosis and necrosis, has emerged as a promising serum biomarker across a wide range of epithelial malignancies. This review synthesizes current evidence regarding its diagnostic, prognostic, and predictive roles in oncology, with emphasis on its clinical applicability, limitations, and future perspectives. Elevated baseline concentrations of CYFRA 21-1 consistently correlate with greater tumor burden, advanced stage, and poorer survival in cancers such as non–small cell lung cancer, head and neck squamous carcinoma, esophageal, colorectal, breast, thyroid, and urothelial tumors. Serial measurement provides additional clinical insight, as reductions during treatment reflect therapeutic response, whereas rising levels may precede radiologic or clinical relapse. Despite these strengths, limited sensitivity in early-stage disease, biological heterogeneity, and lack of assay standardization currently restrict universal application. Integrative approaches combining CYFRA 21-1 with complementary tumor markers, inflammatory indices, or molecular assays show improved diagnostic and prognostic performance, underscoring its potential as part of multimarker algorithms rather than a stand-alone test. Ongoing efforts to harmonize assays, define reference intervals, and evaluate kinetic behavior in prospective cohorts are essential for translation into practice. Ultimately, CYFRA 21-1 represents a biologically grounded, minimally invasive biomarker capable of enhancing personalized oncology by refining risk stratification, guiding therapeutic decisions, and enabling earlier detection of relapse. Continued validation and clinical integration may establish CYFRA 21-1 as a key component in the evolving landscape of evidence-based cancer management.
- 30 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (4(48))
Open AccessCLINICAL UTILITY OF CYFRA 21-1 IN ONCOLOGY: A COMPREHENSIVE REVIEW OF CURRENT EVIDENCE AND FUTURE DIRECTIONS
CYFRA 21-1, a soluble fragment of cytokeratin-19 released during epithelial cell apoptosis and necrosis, has emerged as a promising serum biomarker across a wide range of epithelial malignancies. This review synthesizes current evidence regarding its diagnostic, prognostic, and predictive roles in oncology, with emphasis on its clinical applicability, limitations, and future perspectives. Elevated baseline concentrations of CYFRA 21-1 consistently correlate with greater tumor burden, advanced stage, and poorer survival in cancers such as non–small cell lung cancer, head and neck squamous carcinoma, esophageal, colorectal, breast, thyroid, and urothelial tumors. Serial measurement provides additional clinical insight, as reductions during treatment reflect therapeutic response, whereas rising levels may precede radiologic or clinical relapse. Despite these strengths, limited sensitivity in early-stage disease, biological heterogeneity, and lack of assay standardization currently restrict universal application. Integrative approaches combining CYFRA 21-1 with complementary tumor markers, inflammatory indices, or molecular assays show improved diagnostic and prognostic performance, underscoring its potential as part of multimarker algorithms rather than a stand-alone test. Ongoing efforts to harmonize assays, define reference intervals, and evaluate kinetic behavior in prospective cohorts are essential for translation into practice. Ultimately, CYFRA 21-1 represents a biologically grounded, minimally invasive biomarker capable of enhancing personalized oncology by refining risk stratification, guiding therapeutic decisions, and enabling earlier detection of relapse. Continued validation and clinical integration may establish CYFRA 21-1 as a key component in the evolving landscape of evidence-based cancer management.
- Open Access
- 3 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 85, 66384
Optimizing Pain Management in Truncal Surgery: A Narrative Review of Regional Anesthetic Techniques
Background. Effective postoperative analgesia is essential for optimizing recovery and enhancing patient satisfaction after surgery. Regional anesthesia techniques, particularly fascial plane blocks, are key components of multimodal analgesia, offering targeted somatic and sometimes visceral pain relief.Aim. To review the indications, techniques, efficacy, contraindications, and complications of commonly used truncal regional anesthesia blocks, including TAP, subcostal TAP, quadratus lumborum, rectus sheath, ilioinguinal/iliohypogastric, intercostal, PECS I & II, and serratus anterior plane blocks.Material and methods. A narrative review of recent clinical studies and systematic reviews was performed, focusing on ultrasound-guided fascial plane blocks in abdominal, thoracic, and breast surgeries. Data on efficacy, safety, and clinical application were synthesized to guide perioperative analgesic strategies.Results. TAP and subcostal TAP blocks effectively reduce somatic pain after lower and upper abdominal surgery, respectively, while quadratus lumborum blocks provide both somatic and visceral analgesia. Rectus sheath and ilioinguinal/iliohypogastric blocks are effective for midline and lower abdominal procedures. Intercostal, PECS, and serratus anterior plane blocks offer targeted analgesia for thoracic and breast surgery. Ultrasound guidance enhances safety and efficacy. Complications are rare and include local anesthetic toxicity, bleeding, infection, or block failure, with specific risks such as pneumothorax (ICNB) or transient femoral nerve palsy (TAP, ilioinguinal/iliohypogastric).Conclusions. Truncal regional anesthesia techniques play a vital role in multimodal analgesia, improving pain control, reducing opioid use, and supporting enhanced recovery after surgery. Optimal block selection should be tailored to the surgical site and patient factors. Further high-quality studies are needed to refine techniques and optimize outcomes.
- 3 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 85, 66384
Open AccessOptimizing Pain Management in Truncal Surgery: A Narrative Review of Regional Anesthetic Techniques
Background. Effective postoperative analgesia is essential for optimizing recovery and enhancing patient satisfaction after surgery. Regional anesthesia techniques, particularly fascial plane blocks, are key components of multimodal analgesia, offering targeted somatic and sometimes visceral pain relief.Aim. To review the indications, techniques, efficacy, contraindications, and complications of commonly used truncal regional anesthesia blocks, including TAP, subcostal TAP, quadratus lumborum, rectus sheath, ilioinguinal/iliohypogastric, intercostal, PECS I & II, and serratus anterior plane blocks.Material and methods. A narrative review of recent clinical studies and systematic reviews was performed, focusing on ultrasound-guided fascial plane blocks in abdominal, thoracic, and breast surgeries. Data on efficacy, safety, and clinical application were synthesized to guide perioperative analgesic strategies.Results. TAP and subcostal TAP blocks effectively reduce somatic pain after lower and upper abdominal surgery, respectively, while quadratus lumborum blocks provide both somatic and visceral analgesia. Rectus sheath and ilioinguinal/iliohypogastric blocks are effective for midline and lower abdominal procedures. Intercostal, PECS, and serratus anterior plane blocks offer targeted analgesia for thoracic and breast surgery. Ultrasound guidance enhances safety and efficacy. Complications are rare and include local anesthetic toxicity, bleeding, infection, or block failure, with specific risks such as pneumothorax (ICNB) or transient femoral nerve palsy (TAP, ilioinguinal/iliohypogastric).Conclusions. Truncal regional anesthesia techniques play a vital role in multimodal analgesia, improving pain control, reducing opioid use, and supporting enhanced recovery after surgery. Optimal block selection should be tailored to the surgical site and patient factors. Further high-quality studies are needed to refine techniques and optimize outcomes.
- Open Access
- 29 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMER’S DISEASE - A NARRATIVE REVIEW
Alzheimer’s disease represents one of the major healthcare issues due to the aging global population and increased life expectancy. Neuropsychiatric symptoms are recognized as integral features of the disease. While previously believed to occur predominantly in the later stages, current evidence indicates that they frequently emerge during the earliest stages of the disease. Depression is associated with faster cognitive decline and increased disease burden. Although SSRIs are frequently used, their efficacy remains inconsistent. Apathy is one of the most prevalent neuropsychiatric symptoms in AD, arising from disruptions in motivation-related neural circuits and modulated by neuroinflammatory, genetic, and personality factors. Although no treatment is currently approved, catecholaminergic agents show the most consistent promise in reducing apathy. Psychosis, encompassing delusions, hallucinations, affects over half of patients. Agitation impairs patient’s and caregiver’s function. Aggression is linked to disruptions in serotonergic signaling, frontal lobe dysfunction, and psychotic features, with prevalence increasing as the disease progresses. Traditional antipsychotics pose safety risks, novel agents such as brexpiprazole, pimavanserin, and cannabinoids offer promising therapeutic approaches. Sleep disturbances such as reductions in slow-wave and REM sleep, as well as fragmented sleep architecture, are among the earliest symptoms and contribute to cognitive decline through impaired memory consolidation and altered clearance of neurotoxic proteins. Drugs such as suvorexant and melatonin show promising results. Despite extensive research over the years, effective therapy for neuropsychiatric symptoms remains elusive. In this review, current understanding of the neuropsychiatric symptoms and their therapy is highlighted.
- 29 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
Open AccessNEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMER’S DISEASE - A NARRATIVE REVIEW
Alzheimer’s disease represents one of the major healthcare issues due to the aging global population and increased life expectancy. Neuropsychiatric symptoms are recognized as integral features of the disease. While previously believed to occur predominantly in the later stages, current evidence indicates that they frequently emerge during the earliest stages of the disease. Depression is associated with faster cognitive decline and increased disease burden. Although SSRIs are frequently used, their efficacy remains inconsistent. Apathy is one of the most prevalent neuropsychiatric symptoms in AD, arising from disruptions in motivation-related neural circuits and modulated by neuroinflammatory, genetic, and personality factors. Although no treatment is currently approved, catecholaminergic agents show the most consistent promise in reducing apathy. Psychosis, encompassing delusions, hallucinations, affects over half of patients. Agitation impairs patient’s and caregiver’s function. Aggression is linked to disruptions in serotonergic signaling, frontal lobe dysfunction, and psychotic features, with prevalence increasing as the disease progresses. Traditional antipsychotics pose safety risks, novel agents such as brexpiprazole, pimavanserin, and cannabinoids offer promising therapeutic approaches. Sleep disturbances such as reductions in slow-wave and REM sleep, as well as fragmented sleep architecture, are among the earliest symptoms and contribute to cognitive decline through impaired memory consolidation and altered clearance of neurotoxic proteins. Drugs such as suvorexant and melatonin show promising results. Despite extensive research over the years, effective therapy for neuropsychiatric symptoms remains elusive. In this review, current understanding of the neuropsychiatric symptoms and their therapy is highlighted.
- Open Access
- 26 April 2024
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e943798-e943798-8
Lung Lesions: Differential Diagnoses Beyond Cancer
Objective: Unusual clinical course Background: Lung cancer is the most common malignant neoplasm diagnosed worldwide. Early diagnosis and treatment are of great importance for patient's prognosis. A wide variety of pulmonary conditions display clinical and radiological presentation similar to that of lung cancer, and the awareness of their existence can help in making correct diagnoses. Case Reports: This article presents a description of 4 patients with an insidious type of lesions mimicking pulmonary carcinomas. The first patient was referred to Department with a tumor-like lesion in the right lung. After CT of the chest and core-needle biopsy, the lesion turned out to be an ectopic thyroid tissue. The second patient reported a dry cough and weight loss. A lung nodule mass was revealed in chest CT and the patient was diagnosed with pulmonary tuberculoma. The remaining 2 patients, despite the suspicion of lung cancer, were subsequently diagnosed with a post-traumatic pleural hematoma and diffuse large B cell lymphoma. Conclusions: Low-dose computed tomography of the chest plays a significant role in the diagnosis of newly detected lesions in the lungs. However, due to the similarity of the image of cancer to that of other diseases, the ultimate diagnosis should be based on the interpretation of full imaging diagnostic tests, clinical presentation, and histopathological examination of the material obtained from the lesion. Analysis of cases enables us to expand our understanding of the diseases that need to be considered in differential diagnosis of a patient with a detected tumor-like lesion in the lungs.
- 26 April 2024
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e943798-e943798-8
Open AccessLung Lesions: Differential Diagnoses Beyond Cancer
Objective: Unusual clinical course Background: Lung cancer is the most common malignant neoplasm diagnosed worldwide. Early diagnosis and treatment are of great importance for patient's prognosis. A wide variety of pulmonary conditions display clinical and radiological presentation similar to that of lung cancer, and the awareness of their existence can help in making correct diagnoses. Case Reports: This article presents a description of 4 patients with an insidious type of lesions mimicking pulmonary carcinomas. The first patient was referred to Department with a tumor-like lesion in the right lung. After CT of the chest and core-needle biopsy, the lesion turned out to be an ectopic thyroid tissue. The second patient reported a dry cough and weight loss. A lung nodule mass was revealed in chest CT and the patient was diagnosed with pulmonary tuberculoma. The remaining 2 patients, despite the suspicion of lung cancer, were subsequently diagnosed with a post-traumatic pleural hematoma and diffuse large B cell lymphoma. Conclusions: Low-dose computed tomography of the chest plays a significant role in the diagnosis of newly detected lesions in the lungs. However, due to the similarity of the image of cancer to that of other diseases, the ultimate diagnosis should be based on the interpretation of full imaging diagnostic tests, clinical presentation, and histopathological examination of the material obtained from the lesion. Analysis of cases enables us to expand our understanding of the diseases that need to be considered in differential diagnosis of a patient with a detected tumor-like lesion in the lungs.
- Open Access
Telemedicine in Primary Practice in the Age of the COVID-19 Pandemic—Review
Background and Objectives: In the era of the COVID-19 pandemic, telemedicine, so far underestimated, has gained in value. Currently, telemedicine is not only a telephone or chat consultation, but also the possibility of the remote recording of signals (such as ECG, saturation, and heart rate) or even remote auscultation of the lungs. The objective of this review article is to present a potential role for, and disseminate knowledge of, telemedicine during the COVID-19 pandemic. Material and Methods: In order to analyze the research material in accordance with PRISMA guidelines, a systematic search of the ScienceDirect, Web of Science, and PubMed databases was conducted. Out of the total number of 363 papers identified, 22 original articles were subjected to analysis. Results: This article presents the possibilities of remote patient registration, which contributes to an improvement in remote diagnostics and diagnoses. Conclusions: Telemedicine is, although not always and not by everyone, an accepted form of providing medical services. It cannot replace direct patient–doctor contact, but it can undoubtedly contribute to accelerating diagnoses and improving their quality at a distance.
Open AccessTelemedicine in Primary Practice in the Age of the COVID-19 Pandemic—Review
Background and Objectives: In the era of the COVID-19 pandemic, telemedicine, so far underestimated, has gained in value. Currently, telemedicine is not only a telephone or chat consultation, but also the possibility of the remote recording of signals (such as ECG, saturation, and heart rate) or even remote auscultation of the lungs. The objective of this review article is to present a potential role for, and disseminate knowledge of, telemedicine during the COVID-19 pandemic. Material and Methods: In order to analyze the research material in accordance with PRISMA guidelines, a systematic search of the ScienceDirect, Web of Science, and PubMed databases was conducted. Out of the total number of 363 papers identified, 22 original articles were subjected to analysis. Results: This article presents the possibilities of remote patient registration, which contributes to an improvement in remote diagnostics and diagnoses. Conclusions: Telemedicine is, although not always and not by everyone, an accepted form of providing medical services. It cannot replace direct patient–doctor contact, but it can undoubtedly contribute to accelerating diagnoses and improving their quality at a distance.